Plain-English translation of NCT06433817 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether spectral CT—a more detailed type of imaging scan—can help doctors plan and deliver radiation therapy more effectively for people with cervical cancer. Researchers will use these advanced scans to see if they can improve how radiation therapy is targeted and monitored during treatment.
Current radiation therapy planning relies on standard imaging, but newer scanning technology may provide clearer pictures of tumors and surrounding tissues, potentially allowing doctors to deliver more precise and effective treatment while reducing side effects.
You likely qualify if…
You likely don't qualify if…
You will undergo special spectral CT scans during two phases—when contrast dye is traveling through your arteries and when it flows through your veins—to help doctors see your tumor in greater detail. These scans will be used alongside your regular radiation therapy planning and treatment. The study will involve imaging appointments in addition to your standard cancer care visits.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China
Enrollment target
~150 participants
Started
May 2024
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fuquan Zhang, Porf
Peking Union Medical College Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.